EcoDrugPlus

Retinoic Acid Receptor Alpha

Ensembl ID : ENSOCUG00000004903
Gene Symbol: RARA
3 Cross references
331 Possible Orthologues:

Retinoic Acid Receptor Beta

Ensembl ID : ENSOCUG00000000714
Gene Symbol: RARB
2 Cross references
450 Possible Orthologues:

Retinoid X Receptor Beta

Ensembl ID : ENSOCUG00000011590
Gene Symbol: RXRB
2 Cross references
234 Possible Orthologues:

Retinoid X Receptor Gamma

Ensembl ID : ENSOCUG00000005512
Gene Symbol: RXRG
3 Cross references
273 Possible Orthologues:

Ribosomal Protein L12

Ensembl ID : ENSOCUG00000004902
Gene Symbol: RPL12
2 Cross references
222 Possible Orthologues:

Ribosomal Protein L13a

Ensembl ID : ENSOCUG00000025258
Gene Symbol: RPL13A
2 Cross references
240 Possible Orthologues:

Ribosomal Protein L14

Ensembl ID : ENSOCUG00000010309
Gene Symbol: RPL14
3 Cross references
267 Possible Orthologues:

Ribosomal Protein L18a

Ensembl ID : ENSOCUG00000024833
Gene Symbol: RPL18A
3 Cross references
349 Possible Orthologues:

Ribosomal Protein L23

Ensembl ID : ENSOCUG00000013915
Gene Symbol: RPL23
3 Cross references
132 Possible Orthologues:

Ribosomal Protein L26

Ensembl ID : ENSOCUG00000006538
Gene Symbol: RPL26
3 Cross references
214 Possible Orthologues:

Ribosomal Protein L28

Ensembl ID : ENSOCUG00000027112
Gene Symbol: RPL28
3 Cross references
182 Possible Orthologues:

Ribosomal Protein L30

Ensembl ID : ENSOCUG00000017386
Gene Symbol: RPL30
3 Cross references
317 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).